Priming with GM-CSF prior to high-dose CEP chemotherapy

被引：0
|
作者：
Rivkin, SE
Hayes, FA
Fagnan, L
Oien, T
KlemolaPhillips, R
机构：
[1] SWEDISH MED CTR,INST TUMOR,SEATTLE,WA
[2] IMMUNEX CORP,SEATTLE,WA
来源：
BLOOD | 1995年 / 86卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：3951 / 3951
页数：1
相关论文
共 50 条
  • [1] USE OF GM-CSF IN CHILDREN AFTER HIGH-DOSE CHEMOTHERAPY
    FURMAN, WL
    FAIRCLOUGH, D
    CAIN, AM
    ARNOLD, BA
    PRATT, CB
    MEYER, WH
    CRIST, WM
    MEDICAL AND PEDIATRIC ONCOLOGY, 1992, : 26 - 30
  • [2] IN-VIVO PROFIBRINOLYTIC EFFECT OF GM-CSF IN PATIENTS TREATED WITH HIGH-DOSE CHEMOTHERAPY
    TAMPONI, G
    BAZZAN, M
    PANNOCCHIA, A
    STELLA, S
    GARBARINO, G
    TARELLA, C
    PILERI, A
    THROMBOSIS AND HAEMOSTASIS, 1993, 69 (06) : 1037 - 1037
  • [3] Prospective randomized clinical trial comparing high-dose ifosfamide + GM-CSF vs high-dose cyclophosphamide + GM-CSF for blood progenitor cell mobilization
    J Vela-Ojeda
    F Tripp-Villanueva
    L Montiel-Cervantes
    E Sánchez-Cortés
    M Ayala-Sánchez
    ME Guevara-Moreno
    LD García-León
    A Rosas-Cabral
    MA García-Ruiz Esparza
    J González-Llaven
    Bone Marrow Transplantation, 2000, 25 : 1141 - 1146
  • [4] GM-CSF AND DOSE-ESCALATION OF CHEMOTHERAPY
    AGLIETTA, M
    ANNALS OF ONCOLOGY, 1994, 5 (07) : 663 - 663
  • [5] Survival benefit with GM-CSF use after high-dose chemotherapy in high-risk breast cancer
    Kuzhan, Okan
    Oezet, Ahmet
    Ulutin, Cuneyt
    Koemuercue, Seref
    Arpaci, Fikret
    Oeztuerk, Bekir
    Oeztuerk, Mustafa
    TUMORI JOURNAL, 2007, 93 (06): : 550 - 556
  • [6] RESPONSE TO HIGH-DOSE CYCLOPHOSPHAMIDE WITH GM-CSF IN MERKEL CELL TUMOR
    STOCK, W
    LICHTMAN, S
    RATAIN, MJ
    OBREIN, S
    VOGELZANG, NJ
    VANECHO, DA
    ANNALS OF ONCOLOGY, 1991, 2 (07) : 522 - 523
  • [7] Prospective randomized clinical trial comparing high-dose ifosfamide plus GM-CSF vs high-dose cyclophosphamide plus GM-CSF for blood progenitor cell mobilization
    Vela-Ojeda, J
    Tripp-Villanueva, F
    Montiel-Cervantes, L
    Sánchez-Cortés, E
    Ayala-Sánchez, M
    Guevara-Moreno, ME
    García-León, LD
    Rosas-Cabral, A
    Esparza, MAGR
    González-Llaven, J
    BONE MARROW TRANSPLANTATION, 2000, 25 (11) : 1141 - 1146
  • [8] Granulocyte-macrophage colony-stimulating factor (GM-CSF) priming of high-dose etoposide and cyclophosphamide: A pilot trial
    Bernstein, SH
    Christiansen, NP
    Fay, JP
    Brown, R
    Herzig, R
    Frankel, S
    Blumenson, L
    Herzig, GP
    EXPERIMENTAL HEMATOLOGY, 1996, 24 (12) : 1363 - 1368
  • [9] Randomized trial of GM-CSF and G-CSF following high-dose cytarabine and mitoxantrone chemotherapy for relapsed and refractory acute leukemia.
    Baer, Maria R.
    Ford, Laurie A.
    Bundy, Brian N.
    Tighe, Sheila M.
    O'Loughlin, Kieran L.
    Slack, James L.
    Wetzler, Meir
    Wallace, Paul K.
    BLOOD, 2006, 108 (11) : 223B - 223B
  • [10] The effect on thrombocytopenia of PIXY321, GM-CSF, G-CSF and SCT/GM-CSF following the CEP regimen
    Giles, F
    Wolin, E
    Lim, S
    Kanemaki, T
    Fuerst, M
    THROMBOSIS AND HAEMOSTASIS, 1997, : PS518 - PS518
12345